Advertisement

Applied Microbiology and Biotechnology

, Volume 72, Issue 4, pp 732–737 | Cite as

Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries

  • Carina Krüger
  • Anna Hultberg
  • Harold Marcotte
  • Pim Hermans
  • Sandra Bezemer
  • Leon G. J. Frenken
  • Lennart HammarströmEmail author
Biotechnologically Relevant Enzymes and Proteins

Abstract

Streptococcus mutans is the main cause of dental caries. We evaluated the therapeutic effect of variable regions of a llama heavy chain antibody fragments directed against S. mutans named S36-VHH (S for Streptococcus) alone or fused with glucose oxidase (GOx) from Aspergillus niger. Western blot analysis and ELISA revealed binding of the S36-VHH to the streptococcal antigen I/II adhesin molecule of S. mutans serotype C. In a rat-desalivated caries model, daily administration of S36-VHH significantly reduced the development of smooth surface caries. No additional therapeutic effect of GOx was observed. Our results suggest that llama VHH antibodies may be a potential benefit as prophylaxis against dental caries.

Keywords

Dental Caries Streptococcus Mutans Heavy Chain Antibody Streptococcal Antigen Talon Metal Affinity Resin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgement

This work was supported by the Foundation for Preventive Caries Research (Patentmedelsfonden) and the Swedish Research Council.

References

  1. Bleiweiss AS, Lee SF, Brady LJ, Progulske-Fox A, Crowley PJ (1990) Cloning and inactivation of the gene responsible for a major surface antigen on Streptococcus mutans. Arch Oral Biol 35:15–23CrossRefGoogle Scholar
  2. Bowen WH, Pearson SK, Young DA (1988) The effect of desalivation on coronal root surface caries in rats. J Dent Res 6:21–23Google Scholar
  3. De Haard HJ, Bezemer S, Ledeboer AM, Muller WH, Boender PJ, Moineau S, Coppelmans MC, Verkleij AJ, Frenken LG, Verrips CT (2005) Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection. J Bacteriol 187:4531–4541CrossRefGoogle Scholar
  4. Frenken LGJ, van der Linden RHJ, Hermans PWJJ, Bos JW, Ruuls RC, De Geus B, Verrips CT (2000) Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 78:11–21CrossRefGoogle Scholar
  5. Kelly C, Evans P, Bergmeier L, Lee SF, Progulske-Fox A, Harris AC, Aitken A, Bleiweiss AS, Lehner T (1989) Sequence analysis of the cloned streptococcal antigen I/II. FEBS Lett 258:127–132CrossRefGoogle Scholar
  6. Keyes PH (1958) Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously. J Dent Res 37:1088–1099Google Scholar
  7. Koga T, Oho T, Shimazaki Y, Nakano Y (2002) Immunization against dental caries. Vaccine 20:2027–2044CrossRefGoogle Scholar
  8. Krüger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, van Dollenweerd C, Ma JK, Hammarström L (2002) In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 20:702–706CrossRefGoogle Scholar
  9. Krüger C, Pearson SK, Kodama Y, Vacca Smith A, Bowen WH, Hammarström L (2004) The effects of egg-derived antibodies to glucosyltransferases on dental caries in rats. Caries Res 38:9–14Google Scholar
  10. Krüger C, Hultberg A, van Dollenweerd C, Marcotte H, Hammarström L (2005) Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans. Mol Biotechnol 31:221–232CrossRefGoogle Scholar
  11. Ma JKC, Smith R, Lehner T (1987) Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect Immun 55:1274–1278Google Scholar
  12. Marcotte H, Lavoie MC (1998) Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 62:71–109Google Scholar
  13. Muyldermans S, Atarhouch T, Saldana J (1999) Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J Mol Recognit 12:131–140CrossRefGoogle Scholar
  14. Payne G (2003) Progress in immunoconjugate cancer therapeutics. Cancer Cell 3:207–212CrossRefGoogle Scholar
  15. Smith DJ, King WF, Barnes LA, Peacock Z, Taubman MA (2003a) Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B. Infect Immun 71:1179–1184CrossRefGoogle Scholar
  16. Smith DJ, Lam A, Barnes LA, King WF, Peacock Z, Wise DL, Trantolo DJ, Taubman MA (2003b) Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity. Oral Microbiol Immunol 18:240–248CrossRefGoogle Scholar
  17. Szynol A, de Soet JJ, Sieben-van Tuyl E, Bos JW, Frenken LG (2004) Bactericidal effects of a fusion protein of llama heavy-chain antibodies coupled to glucose oxidase on oral bacteria. Antimicrob Agents Chemother 48:3390–3395CrossRefGoogle Scholar
  18. Thomas EL, Milligan TW, Joyner RE, Jefferson MM (1994) Antibacterial activity of hydrogen peroxide and the lactoperoxidase-hydrogen peroxide-thiocyanate system against oral streptococci. Infect Immun 62:529–535Google Scholar
  19. Thomassen YE, Verkleij AJ, Boonstra J, Verrips CT (2005) Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation. J Biotechnol 118:270–277CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Carina Krüger
    • 1
  • Anna Hultberg
    • 1
  • Harold Marcotte
    • 1
  • Pim Hermans
    • 2
  • Sandra Bezemer
    • 2
  • Leon G. J. Frenken
    • 3
  • Lennart Hammarström
    • 1
    Email author
  1. 1.Division of Clinical ImmunologyKarolinska Institutet at Karolinska University HospitalStockholmSweden
  2. 2.Biotechnology Application Centre (BAC) BVNaardenThe Netherlands
  3. 3.Unilever Foods and Health Research InstituteVlaardingenThe Netherlands

Personalised recommendations